NEI Research News

NEI-funded investigators at Washington University in St. Louis discovered a potential new treatment approach to diabetic retinopathy, one of the most common causes of vision loss in the U.S.

In primates, activity in the visual cortex—a part of the brain that processes signals from the eyes—is largely unaffected by the body’s own movements, according to a new study from scientists at the National Eye Institute (NEI).

A summary of the April 11, 2023, workshop, "NEI-NIMHD Vision Health Equity Workshop," is available on the NEI website.

Ribosomal protein genes that are found at low levels in adult nerve cells may be very important to axon regeneration.

Ruchi Sharma, Ph.D., a staff scientist in the NEI Ocular and Stem Cell Translational Section, received an award from the Knights Templar Eye Foundation (KTEF), a charity sponsored by the Grand Encampment of Knights Templar.

Scientists have invested decades in piecing together how our vision is so good at recognizing what’s familiar. A new study overcomes an apparent discrepancy in data to reveal a new insight into how it works.

University of California Irvine (UCI) researchers believe they have discovered a special antibody that may lead to a treatment for an inherited eye disease called retinitis pigmentosa.

Researchers have successfully transplanted human microglia into mouse retina to create a model for studying eye disease treatments, such as diabetic retinopathy, glaucoma and age-related macular degeneration.

A team of researchers from NYU has demonstrated that the key to understanding working memory relies not only on what one is storing in memory, but also why.

The Noelin family of secreted proteins bind to the external portion of AMPA glutamate receptors and stabilize them on the neuronal cellular membrane, a process necessary for transmission of full-strength signals between neurons.